Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Cutaneous Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Aung Naing, MD) · anaing@mdanderson.org · 713-563-3885
Contact: Principal Investigator (Aung Naing, MD)

Study leads

Aung Naing, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer

Advanced Head and Neck Squamous Cell Carcinoma · Resectable Head and Neck Squamous Cell Carcinoma · Stage II Head and Neck Cutaneous Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States

Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma

Cutaneous Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Wollstonecraft, Australia

MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer

Cutaneous Squamous Cell Carcinoma (CSCC)

Abroad (travel likely)RecruitingPHASE2

Burlington, United States

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

Cutaneous Squamous Cell Carcinoma · Skin Cancers - Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Pittsburgh, United States